113 related articles for article (PubMed ID: 11956594)
1. Evidence for hormone-responsive cleavage of gonadotropin-releasing hormone by the plasma membrane of ovarian cancer cells.
Imai A; Iida K; Furui T; Tamaya T
Int J Oncol; 2002 May; 20(5):987-92. PubMed ID: 11956594
[TBL] [Abstract][Full Text] [Related]
2. Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation.
Sugiyama M; Imai A; Furui T; Tamaya T
Oncol Rep; 2003; 10(6):1885-9. PubMed ID: 14534713
[TBL] [Abstract][Full Text] [Related]
3. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells.
Imai A; Furui T; Tamaya T; Mills GB
J Clin Endocrinol Metab; 2000 Sep; 85(9):3370-5. PubMed ID: 10999836
[TBL] [Abstract][Full Text] [Related]
4. Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas.
Takagi H; Imai A; Furui T; Horibe S; Fuseya T; Tamaya T
Gynecol Oncol; 1995 Jul; 58(1):110-5. PubMed ID: 7789876
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers.
Furui T; Imai A; Tamaya T
Oncol Rep; 2002; 9(2):349-52. PubMed ID: 11836606
[TBL] [Abstract][Full Text] [Related]
6. Effects of GnRH analogs on six ovarian cancer cell lines in culture.
Connor JP; Buller RE; Conn PM
Gynecol Oncol; 1994 Jul; 54(1):80-6. PubMed ID: 8020844
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells.
Sugiyama M; Imai A; Furui T; Tamaya T
Oncol Rep; 2005 May; 13(5):813-7. PubMed ID: 15809743
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
Choi JH; Choi KC; Auersperg N; Leung PC
Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
[TBL] [Abstract][Full Text] [Related]
9. Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane.
Imai A; Takagi H; Furui T; Horibe S; Fuseya T; Tamaya T
Cancer; 1996 Jan; 77(1):132-7. PubMed ID: 8630919
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
So WK; Cheng JC; Poon SL; Leung PC
FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
Fister S; Günthert AR; Emons G; Gründker C
Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
[TBL] [Abstract][Full Text] [Related]
12. Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell.
Sun WS; Imai A; Sugiyama M; Furui T; Tamaya T; Saio M; Morris AJ
Am J Obstet Gynecol; 2004 Jul; 191(1):143-9. PubMed ID: 15295355
[TBL] [Abstract][Full Text] [Related]
13. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
[TBL] [Abstract][Full Text] [Related]
14. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
15. Action of gonadotropin-releasing hormone II on the baboon ovary.
Siler-Khodr TM; Grayson M; Eddy CA
Biol Reprod; 2003 Apr; 68(4):1150-6. PubMed ID: 12606432
[TBL] [Abstract][Full Text] [Related]
16. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
18. Gi protein-mediated translocation of serine/threonine phosphatase to the plasma membrane and apoptosis of ovarian cancer cell in response to gonadotropin-releasing hormone antagonist cetrorelix.
Imai A; Sugiyama M; Furui T; Tamaya T
J Obstet Gynaecol; 2006 Jan; 26(1):37-41. PubMed ID: 16390708
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
[TBL] [Abstract][Full Text] [Related]
20. Differential gonadotropin releasing hormone (GnRH) expression, autoregulation and effects in two models of rat luteinized ovarian cells.
Sorianello EM; Fernandez MO; Catalano PN; Mongiat LA; Somoza GM; Libertun C; Lux-Lantos VA
Life Sci; 2005 Sep; 77(17):2141-55. PubMed ID: 16005024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
